Natriuretic Peptide Guideline for Acute Heart Failure Diagnosis

Introduction to Natriuretic Peptide Cutoffs

• The European Society of Cardiology recommends using BNP <100 pg/mL to rule out and >500 pg/mL to rule in acute heart failure, with NT-proBNP using <300 pg/mL to rule out and age-adjusted cutoffs to rule in the diagnosis 1, 2

BNP and NT-proBNP Cutoff Values

• BNP <100 pg/mL effectively excludes acute heart failure with 90% sensitivity and 94% negative predictive value in patients without severe renal failure 1, 2
• NT-proBNP <300 pg/mL excludes acute heart failure with 98% negative predictive value, regardless of age 1, 2, 4, 5
• For patients with severe renal failure, BNP and NT-proBNP cutoffs need to be adjusted, with BNP using 200-225 pg/mL and NT-proBNP using 1200 pg/mL as the rule-out threshold 1, 2

Special Population Considerations

• In severe obesity, BNP and NT-proBNP have reduced sensitivity, with BNP using 55 pg/mL as the rule-out threshold 1, 2
• Obese patients have lower natriuretic peptide levels due to defects in secretion or increased clearance receptors in adipose tissue 1, 2

Prognostic Value of Natriuretic Peptides

• Predischarge NT-proBNP >137 pg/mL indicates poor prognosis and high risk of readmission 3, 6

Clinical Implementation

• The European Society of Cardiology recommends measuring natriuretic peptide immediately upon emergency department presentation with acute dyspnea, and applying rule-out cutoffs first 1, 2, 4, 5
• For values in the gray zone or above the rule-in threshold, proceed immediately to echocardiography 4, 5
• Obtain a second measurement before discharge for risk stratification, with reductions >30% indicating lower risk 3, 6